Tag:
SB1578
Latest Headlines
Latest Headlines
Onyx forges $550M pact for S*Bio programs
Singapore's S*Bio has inked a $550 million licensing deal with Onyx Pharmaceuticals covering the development and commercialization of its JAK2 inhibitors, SB1518 and SB1578. S*Bio gets $25 million of
